Search Results

There are 1378 results for: content related to: Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy

  1. You have free access to this content
    Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort

    Internal Medicine Journal

    Volume 45, Issue 10, October 2015, Pages: 1054–1065, A. Mallett, P. Hughes, J. Szer, A. Tuckfield, C. Van Eps, S. B. Cambell, C. Hawley, J. Burke, J. Kausman, I. Hewitt, A. Parnham, S. Ford and N. Isbel

    Version of Record online : 1 OCT 2015, DOI: 10.1111/imj.12864

  2. You have free access to this content
    Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria

    Intervention Review

    The Cochrane Library

    Arturo J Martí-Carvajal, Vidhu Anand, Andrés Felipe Cardona and Ivan Solà

    Published Online : 30 OCT 2014, DOI: 10.1002/14651858.CD010340.pub2

  3. You have free access to this content
    Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

    Clinical & Experimental Immunology

    Volume 187, Issue 2, February 2017, Pages: 304–315, C. Wehling, O. Amon, M. Bommer, B. Hoppe, K. Kentouche, G. Schalk, R. Weimer, M. Wiesener, B. Hohenstein, B. Tönshoff, R. Büscher, H. Fehrenbach, Ö.-N. Gök and M. Kirschfink

    Version of Record online : 25 NOV 2016, DOI: 10.1111/cei.12890

  4. You have full text access to this OnlineOpen article
    Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    British Journal of Haematology

    Volume 162, Issue 1, July 2013, Pages: 62–73, Peter Hillmen, Petra Muus, Alexander Röth, Modupe O. Elebute, Antonio M. Risitano, Hubert Schrezenmeier, Jeffrey Szer, Paul Browne, Jaroslaw P. Maciejewski, Jörg Schubert, Alvaro Urbano-Ispizua, Carlos de Castro, Gérard Socié and Robert A. Brodsky

    Version of Record online : 25 APR 2013, DOI: 10.1111/bjh.12347

  5. You have free access to this content
    Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

    American Journal of Transplantation

    Volume 11, Issue 11, November 2011, Pages: 2405–2413, M. D. Stegall, T. Diwan, S. Raghavaiah, L. D. Cornell, J. Burns, P. G. Dean, F. G. Cosio, M. J. Gandhi, W. Kremers and J. M. Gloor

    Version of Record online : 22 SEP 2011, DOI: 10.1111/j.1600-6143.2011.03757.x

    Corrected by:

    Erratum: Erratum

    Vol. 13, Issue 1, 241, Version of Record online: 26 DEC 2012

  6. You have free access to this content
    Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

    British Journal of Haematology

    Volume 149, Issue 3, May 2010, Pages: 414–425, Anita Hill, Russell P. Rother, Xunde Wang, Sidney M. Morris, Jr, Kerry Quinn-Senger, Richard Kelly, Stephen J. Richards, Monica Bessler, Leonard Bell, Peter Hillmen and Mark T. Gladwin

    Version of Record online : 8 MAR 2010, DOI: 10.1111/j.1365-2141.2010.08096.x

  7. Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test

    Vox Sanguinis

    Volume 102, Issue 2, February 2012, Pages: 159–166, B. Höchsmann, R. Leichtle, I. von Zabern, S. Kaiser, W. A. Flegel and H. Schrezenmeier

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1423-0410.2011.01530.x

  8. You have free access to this content
    The use of eculizumab in renal transplantation

    Clinical Transplantation

    Volume 27, Issue 3, May/June 2013, Pages: E216–E229, A. Nicholas R. Barnett, Elham Asgari, Paramit Chowdhury, Steven H. Sacks, Anthony Dorling and Nizam Mamode

    Version of Record online : 21 MAR 2013, DOI: 10.1111/ctr.12102

  9. You have free access to this content
    Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

    British Journal of Haematology

    Volume 142, Issue 2, July 2008, Pages: 263–272, Jörg Schubert, Peter Hillmen, Alexander Röth, Neal S. Young, Modupe O. Elebute, Jeffrey Szer, Giacomo Gianfaldoni, Gérard Socié, Paul Browne, Robert Geller, Russell P. Rother and Petra Muus

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2141.2008.07183.x

  10. You have free access to this content
    Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria

    American Journal of Hematology

    Volume 85, Issue 8, August 2010, Pages: 553–559, Peter Hillmen, Modupe Elebute, Richard Kelly, Alvaro Urbano-Ispizua, Anita Hill, Russell P. Rother, Gus Khursigara, Chieh-Lin Fu, Mitsuhiro Omine, Paul Browne and Wendell Rosse

    Version of Record online : 5 MAY 2010, DOI: 10.1002/ajh.21757

  11. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation

    Pediatric Transplantation

    Volume 18, Issue 6, September 2014, Pages: E185–E189, Daniel Ranch, Barrett Crowther, Mazen Arar and Chatchawin Assanasen

    Version of Record online : 14 JUN 2014, DOI: 10.1111/petr.12290

  12. Predictors of hemoglobin response to eculizumab therapy in paroxysmal nocturnal hemoglobinuria

    European Journal of Haematology

    Volume 90, Issue 1, January 2013, Pages: 16–24, Amy E. DeZern, Donna Dorr and Robert A. Brodsky

    Version of Record online : 22 NOV 2012, DOI: 10.1111/ejh.12021

  13. You have free access to this content
    The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab

    British Journal of Haematology

    Volume 149, Issue 3, May 2010, Pages: 446–450, Richard Kelly, Louise Arnold, Stephen Richards, Anita Hill, Charlotte Bomken, John Hanley, Andrew Loughney, Jon Beauchamp, Gus Khursigara, Russell P. Rother, Elizabeth Chalmers, Andrew Fyfe, Edward Fitzsimons, Ryotaro Nakamura, Anna Gaya, Antonio M. Risitano, Jörg Schubert, Derek Norfolk, Nigel Simpson and Peter Hillmen

    Version of Record online : 11 FEB 2010, DOI: 10.1111/j.1365-2141.2010.08099.x

  14. A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

    Muscle & Nerve

    Volume 48, Issue 1, July 2013, Pages: 76–84, James F. Howard Jr., Richard J. Barohn, Gary R. Cutter, Miriam Freimer, Vern C. Juel, Tahseen Mozaffar, Michelle L. Mellion, Michael G. Benatar, Maria Elena Farrugia, Jing Jing Wang, Suneil S. Malhotra, John T. Kissel and the MG Study Group

    Version of Record online : 30 APR 2013, DOI: 10.1002/mus.23839

  15. Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study

    American Journal of Hematology

    Volume 91, Issue 4, April 2016, Pages: 366–370, Michael Loschi, Raphael Porcher, Fiorenza Barraco, Louis Terriou, Mohamad Mohty, Sophie de Guibert, Beatrice Mahe, Richard Lemal, Pierre-Yves Dumas, Gabriel Etienne, Fabrice Jardin, Bruno Royer, Dominique Bordessoule, Pierre Simon Rohrlich, Luc Mathieu Fornecker, Celia Salanoubat, Sebastien Maury, Jean-Yves Cahn, Laure Vincent, Thomas Sene, Sophie Rigaudeau, Stephanie Nguyen, Anne-Claire Lepretre, Jean-Yves Mary, Bernadette Corront, Gerard Socie and Regis Peffault de Latour

    Version of Record online : 18 MAR 2016, DOI: 10.1002/ajh.24278

  16. You have free access to this content
    Management of Paroxysmal Nocturnal Haemoglobinuria: a personal view

    British Journal of Haematology

    Volume 153, Issue 6, June 2011, Pages: 709–720, Lucio Luzzatto, Giacomo Gianfaldoni and Rosario Notaro

    Version of Record online : 22 APR 2011, DOI: 10.1111/j.1365-2141.2011.08690.x

  17. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria

    Pediatric Blood & Cancer

    Volume 61, Issue 9, September 2014, Pages: 1544–1550, Ulrike M. Reiss, Jeffrey Schwartz, Kathleen M. Sakamoto, Geetha Puthenveetil, Masayo Ogawa, Camille L. Bedrosian and Russell E. Ware

    Version of Record online : 29 APR 2014, DOI: 10.1002/pbc.25068

  18. You have free access to this content
    Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 11, November 2015, Pages: 2004–2011, S. T. A. van Bijnen, D. Wouters, G. J. van Mierlo, P. Muus and S. Zeerleder

    Version of Record online : 19 OCT 2015, DOI: 10.1111/jth.13125

  19. You have free access to this content
    Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 9, September 2014, Pages: 1440–1448, M. Cugno, R. Gualtierotti, I. Possenti, S. Testa, F. Tel, S. Griffini, E. Grovetti, S. Tedeschi, S. Salardi, D. Cresseri, P. Messa and G. Ardissino

    Version of Record online : 16 JUL 2014, DOI: 10.1111/jth.12615

  20. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation

    Xenotransplantation

    Volume 23, Issue 2, March/April 2016, Pages: 117–127, Dennis Rataj, Sonja Werwitzke, Birgitt Haarmeijer, Michael Winkler, Wolf Ramackers, Björn Petersen, Heiner Niemann, Annegret Wünsch, Andrea Bähr, Nikolai Klymiuk, Eckhard Wolf, Jan-Michael Abicht, David Ayares and Andreas Tiede

    Version of Record online : 16 JAN 2016, DOI: 10.1111/xen.12218